In this case report, we describe a patient with EGFR-mutated lung adenosquamous carcinoma who exhibited persistent tumor progression despite multiple lines of therapy following resistance to third-generation EGFR-TKIs treatment. This evidence concerns the gene EGFR and neoplasm.